United Kingdom· GB-APID-40605311000001105
Ghryvelin 60mg granules for oral suspension sachets
A macimorelin product containing macimorelin, registered in United Kingdom by Consilient Health Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Macimorelin is registered in 12 of 19 countries.
Countries holding a registration under ATC V04CD06 (macimorelin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Macimorelin · ATC V04CD06
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Macimorelin
- Manufacturer
- Consilient Health Ltd
- Country
- United Kingdom (GB)
- ATC code
- V04CD06
- ATC class
- Macimorelin
- Defined daily dose
- 35 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5391512457297
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
398 interactions on record for macimorelin.
Graded by severity as the source publishes them — 241 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Macimorelin · interactions on record
398 records
- 241 severe
- 154 moderate
- 3 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Macimorelin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGhryvelin 60 mgAtnahs Pharma Netherlands
- CzechiaGHRYVELINAtnahs Pharma Netherlands B.V., Amsterdam
- IrelandGHRYVELIN 60 mg granules for oral suspension in sachetAtnahs Pharma Netherlands B.V.
- IcelandGHRYVELINAtnahs Pharma Netherlands B.V.
- NetherlandsGHRYVELIN 60 mg granulaat voor orale suspensie in sachetAtnahs Pharma Netherlands B.V.
- NorwayGhryvelinAtnahs Pharma Netherlands B.V.
- SwedenGHRYVELIN 60 mg Granulat till oral suspension i dospåseAtnahs Pharma Netherlands B.V.
- United StatesMacrilenAeterna Zentaris GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/85876e73-5f2f-4e92-9eac-9859b76bd98a GET /v1/drugs/85876e73-5f2f-4e92-9eac-9859b76bd98a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40605311000001105",
"desc": "Ghryvelin 60mg granules for oral suspension sachets (Consilient Health Ltd)",
"form": "Granules for oral suspension",
"vpid": "40617711000001100",
"source": "dmd",
"vtm_id": "781267008",
"strength": "60 mg",
"substance": "Macimorelin",
"ingredient": "Macimorelin acetate",
"supplier_code": "10309611000001109"
}See everything about macimorelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.